🧬✨ Over the past months, we’ve highlighted our 14 Yellow4FLAVI partners 🌍💉. From genomics & AI to ethics & coordination, each plays a key role in vaccine innovation. Keep up with us on LinkedIn & check out our website for more updates! www.yellow4flavi.eu

Bluesky : 🔬 Meet our partners: Institut Pasteur! 🏫 Coordinator of Yellow4FLAVI, they lead WPs on virus structure, immune responses, ethics & communication. Using YF17D, they study how flavivirus shape affects immunity to guide future vaccines. 🧬💉🌍 Read more here : www.linkedin.com/posts/yellow...

🔬Meet our partner Università degli Studi di Padova (UNIPD)!🏫One of Italy’s oldest universities, UNIPD supports WP2 in Yellow4FLAVI, studying how prior infections & immune history affect YF17D vaccine responses, improving diagnostics & preparedness.🧬💉 More here : lnkd.in/p/enct47Va

🔬Meet our partner : AIGHD ! 🏫 A leader in global health, AIGHD co-leads WP5 in Yellow4FLAVI, studying how cultural views shape vaccine understanding & crafting strategies to boost vaccine acceptance in diverse communities.🧠💉 Read more here: www.linkedin.com/posts/yellow...

🔬 Meet our partner KU Leuven! 🏫 Belgium’s largest university, KU Leuven studies how YF17D-based vaccines protect against flaviviruses in Yellow4FLAVI, using animal models & human data to reveal how vaccine design and host factors shape immunity. 🧬💉🔎 Read more here: www.linkedin.com/posts/yellow...

🔬 Meet our partners Omniscope ! 🏫 A leader in immune system analysis using AI + single-cell tech. In Yellow4FLAVI, they lead deep immune repertoire studies to uncover how vaccines build long-term protection. Based in Malta & Barcelona! 🧠🧬 Read more here : www.linkedin.com/posts/yellow...

🔬 Meet our partners Inserm & Institut Cochin! 🏫 Experts in immunology & virology, they lead WP4 in Yellow4FLAVI, using advanced imaging & gene analysis of skin biopsies to reveal how immunity begins right at the vaccination site. 🧬🔎💉 Find out more here: www.linkedin.com/posts/yellow...

🔬 Meet our partner Klinikum der Universität München (KUM)! 🏫 As a top German medical center, KUM leads WP2 in Yellow4FLAVI, studying how prior flavivirus exposure shapes YF17D vaccine responses & exploring B/T cell memory to reveal why immunity varies. 🧬💉🔎 More here: www.linkedin.com/feed/update/...

🔬 Meet our partner University of Turku! 🏫 A Finnish leader in immunology, UTU teams study how YF vaccines activate B & dendritic cells, revealing how early immune responses begin. They lead key tasks in WP1 & WP4 of Yellow4FLAVI. 🧬🔎💉 Read more here : www.linkedin.com/posts/yellow...

🔬Meet our partner Charité –Universitätsmedizin Berlin🏫 A top EU hospital, Charité leads WP5 in Yellow4FLAVI, exploring how people perceive vaccine immunity & tailoring strategies to boost trust & uptake, focusing on global, cross-cultural communication.🧠💉 More here : www.linkedin.com/posts/yellow...

🔬Meet our partner CIDEIM🏫 A leader in infectious disease research, CIDEIM leads the Colombian component of WP2 and WP5 in Yellow4FLAVI, studying how dengue exposure affects YF vaccine responses & exploring factors shaping vaccine acceptance in vulnerable communities🌍 www.linkedin.com/posts/yellow...

Exciting news from the European Congress of Virology 2025! Pinja Jalkanen shared Yellow4FLAVI’s work on how B cells help shape immune responses to yellow fever virus.🧠Studying YF17D vs wild-type virus could guide better flavivirus vaccine design.🦠 🔗Read more here: www.yellow4flavi.eu/post/yellow4...

🧬 Meet our partner IZS-Teramo! 🏫 This top Italian One Health institute leads WP1 in Yellow4FLAVI, studying how flavivirus proteins shape immunity & whether exposure to one virus can protect against another—key for future vaccines. 🔎🦠💉 Find out more here : www.linkedin.com/posts/yellow...

🔬 Meet our partners: ImmuneWatch! 🏫 A Belgian bioinformatics spin-off using AI to decode how T cells recognize flaviviruses. In Yellow4FLAVI, they lead WP3, tracking T cell responses to improve yellow fever vaccine design & immunity insights. 🔎💉 Read more here : www.linkedin.com/posts/yellow...

🎉 We just hit 500 followers on LinkedIn! 🎉 A big thank you to everyone supporting Yellow4FLAVI’s mission to advance research on flaviviruses and vaccine-induced immunity. 🦠💉 Make sure to follow us on LinkedIn to stay up to date! ✨ 🔗 www.linkedin.com/company/yell...

🔬 Meet our partners: Ludwig-Maximilians-Universität München (LMU Munich)! 🏫 Their teams study how early immune responses shape yellow fever vaccine effectiveness in Yellow4FLAVI, leading WP4 & contributing to WP1 & WP2. 🔎🧬💉 Read more here: www.linkedin.com/feed/update/...

Thanks @julienpompon.bsky.social for inviting me in wonderful Montpellier. In the oldest faculty of Medicine in the world (A.D. 1220) we talked about our favorite #flavivirus and collaboration between our #HorizonEurope @yellow4flavi.bsky.social and @flavivaccine.bsky.social projects.

🧬 Meet our Partners: Universitätsklinikum Erlangen (UKER)🏫 Prof. Schober’s team studies T cell memory after flavivirus vaccination, revealing keys to long-term immunity. UKER leads WP3 & supports WP2 & WP4 in Yellow4FLAVI. 🤝💉 📸 Photo: Uwe Dettmar. More here: www.linkedin.com/posts/yellow...

🔬Dr. Pinja Jalkanen (Turku) visited Prof. Anne Krug’s (@kruglab.bsky.social) lab (LMU Munich), hosted by Margarita Shnipova, for hands-on training in YF17D virus purification. This exchange boosts collaboration and supports WP1 research on immune response.🤝🧬 👉 www.yellow4flavi.eu/post/trainin...

🔬Spotlight on women’s leadership in Yellow4FLAVI! Dr. Barba-Spaeth @giobarbaspaeth.bsky.social, a molecular & structural virologist, coordinates research on how YF17D vaccine structure drives immunity, unlocking new paths for next-gen vaccines.💉🧠 More on our site: www.yellow4flavi.eu/post/women-s...

🔍A team led by Prof. Anne Krug (@kruglab.bsky.social) studied how specific immune cells respond to YF17D, revealing early immune responses that lead to protective immunity and paving the way for future vaccine breakthroughs.💡🧬 www.yellow4flavi.eu/post/new-pub...

👏Proud to announce @omniscope.bsky.social has joined Yellow4FLAVI via the Hop-On Facility, expanding us to 14 partners in 8 countries🌍They'll lead a new WP3 task on YF17D immune responses🧬Looking forward to the insights and innovation this collaboration will bring ! 🌐Learn more: www.yellow4flavi.eu

Great work by Anne Krug from our @yellow4flavi.bsky.social consortium.

👏Institut Pasteur & Pasteur Network developed a test to isolate antibodies targeting dengue virus envelope protein. It reveals how the immune system responds and supports vaccine efforts. The method may also apply to Zika, Yellow Fever, and West Nile.💡🔬Read more : www.yellow4flavi.eu/post/new-pub...

🚀KU Leuven’s new antiviral assay allows simultaneous screening of compounds against multiple viruses (dengue, yellow fever, Japanese encephalitis) in a single experiment, boosting research efficiency, and expanding possibilities for antiviral discovery.🔬Read more: www.yellow4flavi.eu/post/publica...

👏 YF17D, a gold standard in yellow fever vaccination, is now inspiring vaccines for emerging viruses and diseases like malaria and HIV. Its broad immune response and long-lasting protection offer promising solutions for global health. 🌍💉 Read more here: www.yellow4flavi.eu/post/scienti...

🔬 Join us for the next session in our seminar series about flaviviruses. We are thrilled to host Dr. @julienpompon.bsky.social 📅 Date: April 10th 🕒 Time: 3:00 PM (Online) 🔗 Register now to secure your spot! forms.office.com/e/itCWqHubWV #Flaviviruses #EmergentDisease #Pathogens

🔬News & Views by KU Leuven: T cell-mediated protection in absence of virus neutralizing antibodies. This could shape next-gen vaccines, especially for rapidly mutating viruses. 💉🌍 Read more here: www.yellow4flavi.eu/post/news-vi...

@giobarbaspaeth.bsky.social cial led a thought-provoking seminar on emergent pathogens organised by @lwnvivat.bsky.social titled "Flaviviruses Immunological Crosstalk: The Impact of Vaccination." 💉 Read more here: www.yellow4flavi.eu/post/explori...

🔬Last Wednesday our project hosted the first seminar on emergent pathogens with a special focus on Flaviviruses, featuring Dr. @giobarbaspaeth.bsky.social Read more about the seminar here 👉 lwnvivat.eu/exploring-fl... #Flavivirus #Vaccination #YellowFever #Immunology @yellow4flavi.bsky.social

Dr. Christopher Pell(AIGHD) visited the Yellow4FLAVI team at the Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) in Cali, Colombia. The visit aimed to strengthen collaboration and gain insights into the local vaccination context. www.yellow4flavi.eu/post/social-...

Researchers from CIDEIM and AIGHD visited Cali’s vaccination programme as part of the project to explore how community engagement and health communication strategies improve vaccine uptake 🩺💉 #Vaccination #CommunityEngagement #PublicHealth #Yellow4Flavi www.yellow4flavi.eu/post/cideim-...

👏 Yesterday, we celebrated one year of progress with our second online General Assembly since the kick-off held in March 2024 at Institut Pasteur in Paris. The event united 42 participants from 11 countries around the world🌍 www.yellow4flavi.eu/post/yellow4...

🔬 We're excited to launch a seminar series on emerging pathogens, focusing on flaviviruses! On March 19, Dr. @giobarbaspaeth.bsky.social, coordinator of @yellow4flavi.bsky.social will discuss Flavivirus Immunological Crosstalk & Vaccination. 🔗 Register now: forms.office.com/Pages/Respon...

🦠 How does the yellow fever 17D vaccine trigger immunity? Insights from @yellow4flavi.bsky.social could improve flavivirus vaccines! 📅 Mar 19: Don’t miss Dr. Giovanna Barba-Spaeth at our first emerging pathogens seminar. 🔗 Register here: forms.office.com/Pages/Respon...

📖 👏 New Publication: Baseline Immunity Shapes Yellow Fever Vaccine Response 💡 Our project partners have published a new study examining how the state of our immune system before vaccination affects how we respond to the yellow fever 17D (YF17D) vaccine. 🔗 Read www.yellow4flavi.eu/post/new-pub...

🌍🔬 International Day of Women and Girls in Science 🔬🌍 Today, we celebrate the incredible women scientists, group leads, postdocs, engineers, PhD students, and research project managers driving Yellow4FLAVI forward! 🚀💡 www.yellow4flavi.eu/post/interna...

🌍 Today is World Neglected Tropical Diseases (NTD) Day! 🌍 🦠 Neglected tropical diseases (NTDs) are a group of preventable or treatable diseases that affect more than 1 billion people worldwide. #UniteActEliminate #WorldNTDDay #BeatNTDs #Dengue www.linkedin.com/posts/yellow...

#Dengue cases almost doubled in the EU last year. “Europe is already seeing how #climatechange is creating more favourable conditions for invasive #mosquitos to spread into previously unaffected areas” says ECDC Director Andrea Ammon - @euronews.com www.euronews.com/green/2024/0...

#Dengue is a mosquito-borne viral infection causing a severe flu-like illness and sometimes causing a potentially lethal complication known as severe dengue. @who.int created an infographic to explain everything you need to know about the epidemic. #MedSky #EpiSky

Happy new year from the Yellow4FLAVI Consortium ! The Yellow4FLAVI team sends its warmest wishes to all our partners, collaborators, scientific advisors, and the scientific community. May this year bring innovation, impactful discoveries, and success for us all! www.linkedin.com/posts/yellow...

In social media it's a corny phrase, but I am thrilled, honored, thankful indeed to be appointed as a Heisenberg professor for T cell immunology @unifau.bsky.social. 1/2

A starter pack for PhD students and Postdocs in Immunology to connect 🔽 Drop a 🧬 and I'll add you to the list. Let's build the upcoming immuno community! #ImmunoSky 🧪 go.bsky.app/RABVXY4

Outbreak of yellow fever in the Americas Region:24 deaths out of 50 confirmed cases. On this International Day of #EpidemicPreparedness we are reminded of the risk of re-emergence of old threats and the importance of #research and #vaccination @yellow4flavi.bsky.social www.paho.org/sites/defaul...

Is dengue a tropical infection? Ask again. 199 autochthonous cases have been reported in Fano, Italy in 2024. Out of total 693 cases, 1/3 were due to local transmission (10 in 2020 - 82 in 2023). @yellow4flavi.bsky.social #dengue pmc.ncbi.nlm.nih.gov/articles/PMC.... www.izs.it/IZS/Home_Pag...

🦟 By uniting 13 partners across 7 countries EU and Colombia, we are investigating the mechanisms of yellow fever vaccine-induced immunity, paving the way for new vaccines against dengue, Zika. As climate change extends the reach of disease-carrying mosquitoes, this research is more urgent than ever

On this International Day of #EpidemicPreparedness, we highlight the critical importance of #research and international #collaboration in preventing and responding to global health threats, strengthening global resilience against emerging infectious diseases. www.yellow4flavi.eu/post/raising...

Welcome Nilanshu to the team in Paris!

Yellow4FLAVI's Bluesky account is now live!! #EUproject funded by @EU_HaDEA #HorizonEurope #Health Visit our website yellow4flavi.eu #flavivirus #yellowfever #vaccine #pandemic #zika #dengue #lifesciences #EUcooperation